| methylphenidate prolonged release tablet - 12 hrs acting / Generic mfg. |
NCT00151970: Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD |
|
|
| Completed | 2b | 128 | US | Methylphenidate Transdermal System, MTS, Placebo, Sham Treatment, Concerta, Methylphenidate HCL | Noven Therapeutics, Noven Pharmaceuticals, Inc. | Attention Deficit Disorder With Hyperactivity | 10/06 | 10/06 | | |
NCT00475735: A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) |
|
|
| Completed | 2a | 72 | US | MK0249, Concerta (methylphenidate), CONCERTA®, Placebo | Merck Sharp & Dohme LLC | Attention-Deficit/Hyperactivity Disorder (ADHD) | 04/08 | 04/08 | | |
NCT00550147: Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior. |
|
|
| Completed | 2 | 30 | US | Oros Methylphenidate, Concerta, quetiapine, Seroquel | Indiana University School of Medicine | Attention Deficit Disorder With Hyperactivity | 11/05 | 11/05 | | |
NCT00069927: Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression |
|
|
| Terminated | 2 | 12 | US | Adderall-XR®, dextroamphetamine-amphetamine, Concerta®, methylphenidate hydrochloride | University of South Florida, National Cancer Institute (NCI) | Depression, Neurotoxicity, Unspecified Childhood Solid Tumor, Protocol Specific | 06/06 | 09/06 | | |
NCT00880217: A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
|
|
| Completed | 2 | 430 | US | Atomoxetine 80 mg/d, Placebo, OROS methylphenidate HCl 54 mg/d, JNJ-31001074 3 mg/d, JNJ-31001074 1 mg/d, JNJ-31001074 10 mg/d | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Attention Deficit Hyperactivity Disorder | 01/10 | 01/10 | | |
2006-002249-35: Clinical trial of sustained release methylphenidate for Attention-Deficit-Hyperactivity-Disorder (ADHD) in adult criminal offenders with amphetamine addiction |
|
|
| Completed | 2 | 54 | Europe | Concerta, Capsule*, , Concerta | Addiction Center Stockholm | 54 male prison inmates (27 in each treatment condition) that meet the DSM-IV criteria for amphetamine addiction and for ADHD and who are servicing their prison sentence are recruited. | | | | |
NCT01100268: Enhancing Attention in Adults With Compulsive Hoarding |
|
|
| Completed | 2 | 4 | US | Methylphenidate ER, Concerta | New York State Psychiatric Institute, Hartford Hospital | Hoarding Disorder | 04/11 | 04/11 | | |
NCT01348607: Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy |
|
|
| Terminated | 2 | 1 | US | methylphenidate hydrochloride, methylphenidate HCl, Concerta, modafinil, Provigil, placebo, potato starch placebo, placebo capsule | University of South Florida, National Cancer Institute (NCI) | Central Nervous System Tumor, Pediatric, Fatigue, Specific Disorders of Sleep | 11/12 | 12/12 | | |
| Unknown status | 2 | 90 | US | methylphenidate, Concerta, Methylphenidate, Placebo | University of California, Los Angeles | Methamphetamine Dependence | 07/14 | 07/14 | | |
NCT01399827: Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits |
|
|
| Completed | 2 | 2 | US | ADHD Medication, Methylphenidate extended release (OROS-MPH), Concerta, Vyvanse, Dextroamphetamine, Adderall, Mixed Amphetamine Salts, Amphetamine, Strattera, Atomoxetine, Focalin, Dexmethylphenidate, Omega-3 Fatty Acids, Nordic Natural EPA Xtra | Massachusetts General Hospital | Attention Deficit Hyperactivity Disorder (ADHD), Deficient Emotional Self-Regulation (DESR) | 11/17 | 11/17 | | |
2013-002996-16: ANRS SHS155 STIMAGO: Pilote study to evaluate the benefits and the risks of methylphenidate for the treatment of cocain dependence. ANRS SHS155 STIMAGO : Etude pilote pour l’évaluation des bénéfices et des risques du méthylphénidate pour la prise en charge de la dépendance à la cocaïne. |
|
|
| Not yet recruiting | 2 | 20 | Europe | Prolonged-release tablet, Concerta LP 18 mg | Inserm-ANRS, ANRS | Cocaine dependence Dépendance à la cocaïne, Cocaine dependence Dépendance à la cocaïne, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
| Withdrawn | 2 | 0 | Europe | Methylphenidate Pill, Concerta | ANRS, Emerging Infectious Diseases, Hopital Paul Brousse | Substance-Related Disorders | 12/18 | 03/19 | | |
2022-001906-24: LAMAinDiab - comparison of 2 pharmacological therapies (lisdexamphetamine vs methylphenidate) for pediatric patients with ADHD and type 1 diabetes - a randomized crossover clinical trial LAMAinDiab – porównanie 2 terapii farmakologicznych (lisdeksamfetamina vs metylfenidat) dla pacjentów pediatrycznych z zespołem ADHD i cukrzycą typu 1 - randomizowane krzyżowe badanie kliniczne . |
|
|
| Not yet recruiting | 2 | 150 | Europe | Elvanse, Concerta, Capsule, hard, Prolonged-release tablet | Medical University in Lodz, Agencja Badań Medycznych | Patients with ADHD and type I diabetes. Pacjenci z ADHD i Cukrzycą typu I., Patients with ADHD and type I diabetes. Pacjenci z ADHD i Cukrzycą typu I., Not possible to specify | | | | |
NCT01410942: Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy |
|
|
| Active, not recruiting | 2 | 175 | US | Placebo, sugar pill, Methylphenidate, Methylphenidate Hydrochloride, Ritalin, Concerta, Counseling Sessions, Counseling, Sham Exercise, Standardized Exercise Intervention Program, Cognitive Behavioral Therapy (CBT) | M.D. Anderson Cancer Center, American Cancer Society, Inc. | Prostate Cancer | 02/25 | 02/25 | | |
| Recruiting | 2 | 60 | US | Methylphenidate, Concerta, Ritalin, Placebo | VA Office of Research and Development | PTSD, Stroke | 09/26 | 09/26 | | |
NCT01628029: Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer |
|
|
| Active, not recruiting | 2 | 68 | US | Counseling, Counseling Intervention, Methylphenidate Hydrochloride, Concerta, Quillivant XR, Ritalin, Phototherapy, Actinotherapy, Bright Light Therapy, light therapy, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Sham Intervention, Sham Comparator, Therapeutic Melatonin, Circadin, Melatonin, Melaxen | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder | 12/25 | 12/25 | | |
